Zobrazeno 1 - 10
of 159
pro vyhledávání: '"Sean D. Pokorney"'
Autor:
Allen Wang, MD, Tracy Truong, MB, Eric Black-Maier, MD, Cynthia Green, PhD, Kristen B. Campbell, PharmD, Adam S. Barnett, MD, Janice Febre, BSN, RN, Zak Loring, MD, MHS, Sana M. Al-Khatib, MD, MHS, FHRS, Brett D. Atwater, MD, James P. Daubert, MD, FHRS, Camille Frazier-Mills, MD, MHS, Donald D. Hegland, MD, Kevin P. Jackson, MD, Larry R. Jackson, MD, Jason I. Koontz, MD, PhD, Robert K. Lewis, MD, PhD, Sean D. Pokorney, MD, MBA, Albert Y. Sun, MD, Kevin L. Thomas, MD, Tristam D. Bahnson, MD, FHRS, Jonathan P. Piccini, MD, MHS, FHRS
Publikováno v:
Heart Rhythm O2, Vol 1, Iss 3, Pp 180-188 (2020)
Background: Diabetes mellitus (DM) is an independent risk factor for atrial fibrillation (AF). Few studies have compared clinical outcomes after catheter ablation between patients with and those without DM. Objective: The purpose of this study was to
Externí odkaz:
https://doaj.org/article/31cab37e14b142358c5348dce1923f00
Autor:
Camille G. Frazier-Mills, Lawrence C. Johnson, Ying Xia, Sarah C. Rosemas, Noreli C. Franco, Sean D. Pokorney
Publikováno v:
Diagnostics, Vol 12, Iss 8, p 1977 (2022)
Despite advances in syncope evaluation strategies and risk stratification, the high cost of syncope is largely driven by extensive and often repetitive testing. This analysis of a large deidentified US claims database compared the use of diagnostic t
Externí odkaz:
https://doaj.org/article/bb9137f62e9e41a484b364016cc4692b
Autor:
Naomi C. Sacks, Katie Everson, Maia R. Emden, Phillip L. Cyr, David R. Wood, Sajjad Raza, Kathryn A. Wood, Sean D. Pokorney
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 19 (2020)
Background Information on differences in paroxysmal supraventricular tachycardia (PSVT) diagnosis, healthcare resource use, expenditures, and treatment among women versus men is limited. Methods and Results Study participants identified in the IBM Ma
Externí odkaz:
https://doaj.org/article/3f9101184ffc46f3a66e85decaa0d544
Publikováno v:
HeartRhythm Case Reports, Vol 6, Iss 8, Pp 547- (2020)
Externí odkaz:
https://doaj.org/article/5f18da0bf79c456999b61e99f353a885
Autor:
Jeffrey B. Washam, DaJuanicia N. Holmes, Laine E. Thomas, Sean D. Pokorney, Elaine M. Hylek, Gregg C. Fonarow, Kenneth W. Mahaffey, Bernard J. Gersh, Peter R. Kowey, Jack E. Ansell, Alan S. Go, James A. Reiffel, James V. Freeman, Daniel E. Singer, Gerald Naccarelli, Rosalia Blanco, Eric D. Peterson, Jonathan P. Piccini
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 18 (2018)
Background Chronic kidney disease (CKD) is a common comorbidity in patients with atrial fibrillation. The presence of CKD complicates drug selection for stroke prevention and rhythm control. Methods and Results Patients enrolled in ORBIT AF (Outcomes
Externí odkaz:
https://doaj.org/article/0ef1abfb713f46d0b6b200b18ab7877d
Autor:
Sean D. Pokorney, Jonathan P. Piccini, Susanna R. Stevens, Manesh R. Patel, Karen S. Pieper, Jonathan L. Halperin, Günter Breithardt, Daniel E. Singer, Graeme J. Hankey, Werner Hacke, Richard C. Becker, Scott D. Berkowitz, Christopher C. Nessel, Kenneth W. Mahaffey, Keith A. A. Fox, Robert M. Califf
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 3 (2016)
BackgroundAtrial fibrillation is associated with higher mortality. Identification of causes of death and contemporary risk factors for all‐cause mortality may guide interventions. Methods and ResultsIn the Rivaroxaban Once Daily Oral Direct Factor
Externí odkaz:
https://doaj.org/article/33a31cd1723e455fad43d0a6156902d1
Publikováno v:
Scientifica, Vol 2014 (2014)
Atrial fibrillation is the most common arrhythmia and accounts for one-third of hospitalizations for rhythm disorders in the United States. The prevalence of atrial fibrillation averages 1% and increases with age. With the aging of the population, th
Externí odkaz:
https://doaj.org/article/f2bbdb41141148c69dc7f33fcdd96221
Autor:
Joseph B. Lerman, Derek D. Cyr, Karen Chiswell, Rachel S. Tobin, Marat Fudim, Sean D. Pokorney, Robert J. Mentz, Marc D. Samsky
Publikováno v:
ASAIO Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5775aee18de367249a3636e8a478f84
https://doi.org/10.1097/mat.0000000000001946
https://doi.org/10.1097/mat.0000000000001946
Autor:
Josephine Harrington, Anthony P. Carnicelli, Kaiyuan Hua, Lars Wallentin, Manesh R. Patel, Stefan H. Hohnloser, Robert P. Giugliano, Keith A.A. Fox, Ziad Hijazi, Renato D. Lopes, Sean D. Pokorney, Hwanhee Hong, Christopher B. Granger
Publikováno v:
Circulation.
BACKGROUND: There is uncertainty surrounding the use of direct oral anticoagulants (DOACs) in patients with kidney dysfunction. METHODS: Using the COMBINE AF (A Collaboration Between Multiple Institutions to Better Investigate Non-Vitamin K Antagonis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff5206c9320116faae49675a24b92dd8
https://doi.org/10.1161/circulationaha.122.062752
https://doi.org/10.1161/circulationaha.122.062752
Autor:
Matthew A. Carlisle, Peter Shrader, Marat Fudim, Karen S. Pieper, Rosalia G. Blanco, Gregg C. Fonarow, Gerald V. Naccarelli, Bernard J. Gersh, James A. Reiffel, Peter R. Kowey, Benjamin A. Steinberg, James V. Freeman, Michael D. Ezekowitz, Daniel E. Singer, Larry A. Allen, Paul S. Chan, Sean D. Pokorney, Eric D. Peterson, Jonathan P. Piccini
Publikováno v:
Heart rhythm O2. 3(6Part)
Oral anticoagulation (OAC) reduces the risk of thromboembolic events in patients with atrial fibrillation (AF); however, thromboembolism (TE) still can occur despite OAC. Factors associated with residual risk for stroke, systemic embolism, or transie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92e6bdd00e3d51e17a15ce4704d67dca
https://pubmed.ncbi.nlm.nih.gov/36589908
https://pubmed.ncbi.nlm.nih.gov/36589908